RxDoctor Payments Data

Alicia Belisle

Family · Lakeland, FLNPI 1437604105

Payments from drug & device makers

$285in general payments, 2019–2025

Across 9 payments — averaging $31.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astellas Pharma US Inc$158
  • Daiichi Sankyo Inc.$28
  • GSK$20
  • Optumhealth Care Solutions, LLC$19
  • Pfizer$19
  • AbbVie$15
  • plus $26 from 2 others

What the payments were for

  • Food & beverage$12745%
  • Education$15855%

General payments by program year

21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Astellas Pharma US Inc2$158
Daiichi Sankyo Inc.1$28
GSK1$20
Optumhealth Care Solutions, LLC1$19
Pfizer1$19
AbbVie1$15
Medicem Inc.1$14
Ascend Therapeutics US, LLC1$12

How this compares

$285 in reported general payments places this provider in the 45th percentile of 14,618 family providers in Florida.

See all family providers in Florida

Medicare billing

Part B allowed, 2024
$137,105
Medicare patients
357
Services billed
2,331

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
GemtesaVibegron303$221,168
MyrbetriqMirabegron273$171,500
Estradiol365$29,271
EstringEstradiol30$15,897
Mirabegron ErMirabegron21$9,637
PremarinEstrogens, Conjugated14$6,246
YuvafemEstradiol37$5,614
Methenamine Hippurate16$1,804
NitrofurantoinNitrofurantoin Macrocrystal64$1,772
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst86$1,307
Cephalexin118$1,140
Fluconazole37$1,072
Clobetasol Propionate33$904
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip44$875
Terconazole25$686

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Astellas Pharma US IncMyrbetriq$158$171,500273 claims
PfizerEstring, Premarin$19$22,14344 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 14,618 family providers in Florida.

Other family in Lakeland

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →